Anticus International Corporation: Two '2' New Directors Appointed.

MONTREAL -- Anticus Corporation (Anticus) a public traded company on the OTC: BB exchange (OTCBB:ATCI),("Anticus" or the "company") is pleased to announce the appointment of Mr. Henri Baudet and Dr. Xin Zhao to the Board of Directors.

Mr. Baudet began his career in the banking industry in 1970 in Geneva, Switzerland. He held different management positions in several fields such as administration, stocks and bounds, financial management and corporate finance. In 1986, he was appointed Vice-President at Banque de Depot (a Latsis Group Bank) as head of the Private Customers Division. In 1989 he became Director of JP Jordan & Cie SA, a renowned portfolio management company in Geneva. In 1997, with other partners he founded his own company, AS-B & Cie Sa, based in Geneva dedicated to asset management for private clients. Over the years, Mr. Baudet has developed a great knowledge in Financial Mechanisms as well as an impressive list of contacts in the financial community.

Dr. Xin Zhao is professor and Chair at the Department of Animal Science at Mc Gill University, Montreal, Quebec. In 1989, Dr. Zhao obtained a PHD from Cornell University in animal science Minors in physiology and nutrition. He had previously obtained a Master of Science from Nanjing Agricultural University in China. Over the years, Dr. Zhao has contributed to the publication of numerous articles in specialized Journals.

Both nominations are to be effective March 1st 2006.

We are honoured to welcome Mr. Baudet and Dr. Zhao to the Anticus Board added Mr. Varin Chair and CEO on behalf of the Boards of Directors. The appointment of Mr. Baudet demonstrates our commitment to elevate the credibility of Anticus in the financial community while the nomination of Dr. Zhao will bring the company the necessary expertise in animal nutrition as well as knowledge of the animal feed industry for the company to move forward with production of yeast to be used in animal feed with the use of the recently acquired worldwide exclusive license to the microbiological process known as Prolactis.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995.The statement in this release relating to completion of the acquisition and the positive direction are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the results anticipated by these forward -looking statements may not occur. Factors that could cause or contribute to such differences include, but are not limited to, contractual difficulties which may arise, the failure to obtain Anticus shareholders approval, the future market price of Anticus common stock and the ability to obtain the necessary financing.

Anticus International Corporation (OTC Bulletin Board:ATCI)